arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

HYPERION DEFI, INC.

HYPD
$2.56 ▼ -0.48 (-15.79%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
40 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

HYPERION DEFI, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $36.3M
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC 24.0% ↗
FCF / Share $-0.20 ↗
Trailing P/E 2.5x
Price / Book 0.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

40-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$357.69K
↑ +46.4% —
Net Income Profit after all expenses
$8.84M
— 0.0% —
Operating Margin Operating profit as % of sales
30.5%
↑ +112.8% —
FCF / Share Free cash flow per share
$-0.20
↑ +48.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑
8
Financial Health ↑
12
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 11 years · 40 quarters